Поиск

Автор

Ключевое слово

Коллекция

Дополнительно:

Период публикации

Научный руководитель

Оппонент

По вашему запросу найдено документов: 2551

Страница 1 из 256

TRANSCATHETER MITRAL REPAIR WITH A SUTURELESS NEOCHORDAL DEVICE: PRECLINICAL EXPERIENCE

Weber, A, Carrel, T., Maisano, F., Vogel, R. (2016)

Background An animal study was performed to evaluate technical feasibility and performance of a

MOLECULAR DOCKING AND PRECLINICAL STUDY OF FIVE-MEMBERED S,S-PALLADAHETEROCYCLE AS HEPATOPROTECTIVE AGENT

AKHMADIEV, N.S., AKHMETOVA, V.R., IBRAGIMOV, A.G., GALIMOVA, A.M., GALIMOVA, R.A., AGLETDINOV, E.F., KATAEV, V.A., KHAIRULLINA, V.R. (2019)

), a number of preclinical trials has been conducted Methods: 2D and 3D structures

THROMBOELASTOGRAPHY AS AN INSTRUMENT OF PRECLINICAL STUDIES OF THE POTENTIAL DRUG

URAKOV, A.L., MUSTAFIN, I.G., NABIULLINA, R.M., BASHIROVA, L.I., MOCHALOV, K.S., SAMORODOV, A.V., KHALIULLIN, F.A., LIPATOV, D.O., KORUNAS, V.I., KHALIMOV, A.R. (2020)

at preclinical stage was demonstrated; the possibility of safety assessment for hypercoagulability

THE OFF-LABEL USE OF DRUGS FOR PARENTERAL NUTRITION AS A SOLVENT OF SUBSTANCES SLIGHTLY SOLUBLE IN WATER IN PHARMACOLOGICAL RESEARCH

Urakov, A.L., Mustafin, I.G., Samorodov, A.V., Kamilov, F.K., Khaliullin, F.A. (2017)

of preclinical and clinical studies, the research work enabled to develop the original solvent for poorly soluble

The risk of tumor with the use of recombinant human bone morphogenetic proteins

Mukhametov, U.F., Lyulin, S.V., Borzunov, D.Yu., Sufianov, R.A., Gareev, I.F. (2022)

of some preclinical and clinical studies. Material and methods For a comprehensive search, we used

Heterotopic ossification as a side effect of the use of recombinant human bone morphogenetic proteins

Mukhametov, U.F., Lyulin, S.V., Borzunov, D.Y., Gareev, I.F., Beylerli, O.A., Sufianov, A.A. (2022)

demonstrate cases of HO following the use of rhBMPs in both clinical and preclinical studies and make

Результаты доклинических исследований 4-(2-(4-нитрофенил)-2-оксоэтил)-1-(тиетан-3-ил)- 1Н-1,2,4-триазол-4-ия бромида в отношении системы гемостаза в условиях in vivo

Results of Preclinical Studies of 4-(2-(4-nitrophenyl)-2-oxoethyl)-1-(thietane-3-yl)-1H-1,2,4-triazole-4-th Bromide in Relation to the Hemostasis System in vivo

Ванг, Ю., Булатова, Н. Р., Клен, Е. Э., Розит, Г. А., Никитина, И. Л., Смолярчук, Е. А., Завадич, К. А., Крылова, И. Д., Самородов, А. В., Wang, Yi, Bulatova, Nailya R., Klen, Elena E., Rozit, Galina A., Nikitina, Irina L., Smolyarchuk, Elena A., Zavadich, Ksenia A., Krylova, Irina D., Samorodov, Aleksandr V. (2024)

Results of Preclinical Studies of 4-(2-(4-nitrophenyl)-2-oxoethyl)-1-(thietane-3-yl)-1H-1

Stromal vascular fraction cell therapy: A promising therapeutic method for intracerebral hemorrhage

Gareev, Ilgiz, Beylerli, Ozal, Sufianov, Albert, Pavlov, Valentin, Shi, Huaizhang (2025)

(NGF) further support neuronal survival and repair of neural circuits. Preclinical studies in animal

Enhancers of mesenchymal stem cell stemness and therapeutic potency

Al-Azab, Mahmoud, Idiiatullina, Elina, Safi, Mohammed, Hezam, Kamal (2023)

of cell types, including osteoblasts, chondrocytes, myocytes, and adipocytes. Multiple preclinical

MiRNA regulated therapeutic potential of the stromal vascular fraction: Current clinical applications - A systematic review: SVF and miRNAs

Agaverdiev, Murad, Shamsov, Bedil, Mirzoev, Sorbon, Vardikyan, Andranik, Encarnacion, Manuel Ramirez, Nurmukhametov, Renat, Beilerli, Aferin, Zhang, Bohan, Gareev, Ilgiz, Pavlov, Valentin (2023)

. Over the past 20 years, there has been a trend towards an increase in the number of clinical studies

Страница 1 из 256